16 results
PRE 14A
GLUE
Monte Rosa Therapeutics Inc
12 Apr 23
Preliminary proxy
4:07pm
training in organic chemistry at Stanford University, and a B.S. in chemistry from the Imperial College of Science and Technology.
We believe that Dr
DEF 14A
GLUE
Monte Rosa Therapeutics Inc
27 Apr 22
Definitive proxy
4:10pm
. Phil. in organic chemistry at Oxford University, followed by post-doctorate training in organic chemistry at Stanford University, and a B.S. in chemistry
10-K
j7y2ahd 9ojlror3t
29 Mar 22
Annual report
4:15pm
10-Q
jmbg2qjzth29jh
12 Aug 21
Quarterly report
4:22pm
424B4
01l3ab9 eozcgjx9
25 Jun 21
Prospectus supplement with pricing info
6:08am
S-1/A
mjhooe6biv6av
9 Jun 21
IPO registration (amended)
4:51pm
S-1
EX-10.19
68j rucjtp824m20fxt
4 Jun 21
IPO registration
9:07am
S-1
hljucdw6gco
4 Jun 21
IPO registration
9:07am
DRS/A
n4277 tj3
21 May 21
Draft registration statement (amended)
12:00am
DRS
EX-10.18
i3oyskvm7vokgfa5
19 Apr 21
Draft registration statement
12:00am
DRS
wlnf dmwj
19 Apr 21
Draft registration statement
12:00am
- Prev
- 1
- Next